Everolimus

(7E,15E,17E,19E-3S,6R,9R,10R,12R,14S,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-3-{(R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxaaza[31]annulen-1,5,11,28,29(4H,6H,31H)-penton

Stoffgruppe

Antineoplastisches Mittel, Immunsuppressivum (mTOR-Kinase-Inhibitor)